Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 72 entries
Sorted by: Best Match Show Resources per page
A Case Report of Unilateral Orolingual Angioedema Secondary to Alteplase Administration.

Cureus

Harris D, Harter D.
PMID: 30148021
Cureus. 2018 Jun 23;10(6):e2869. doi: 10.7759/cureus.2869.

Emergency physicians should be aware of adverse drug reactions prior to administering medication. Alteplase, or tissue plasminogen activator (tPA), is a common medication in the emergency department, whether it is being used for a stroke or pulmonary embolus. Angioedema...

Cite
Harris D, Harter D. A Case Report of Unilateral Orolingual Angioedema Secondary to Alteplase Administration. Cureus. 2018;10(6):e2869doi: 10.7759/cureus.2869.
Harris, D., & Harter, D. (2018). A Case Report of Unilateral Orolingual Angioedema Secondary to Alteplase Administration. Cureus, 10(6), e2869. https://doi.org/10.7759/cureus.2869
Harris, Dustin, and Harter, David. "A Case Report of Unilateral Orolingual Angioedema Secondary to Alteplase Administration." Cureus vol. 10,6 (2018): e2869. doi: https://doi.org/10.7759/cureus.2869
Harris D, Harter D. A Case Report of Unilateral Orolingual Angioedema Secondary to Alteplase Administration. Cureus. 2018 Jun 23;10(6):e2869. doi: 10.7759/cureus.2869. PMID: 30148021; PMCID: PMC6107327.
Copy Download .nbib Format: NLM
The Novel Internalins InlP1 and InlP4 and the Internalin-Like Protein InlP3 Enhance the Pathogenicity of .

Frontiers in microbiology

Harter E, Lassnig C, Wagner EM, Zaiser A, Wagner M, Rychli K.
PMID: 31396177
Front Microbiol. 2019 Jul 23;10:1644. doi: 10.3389/fmicb.2019.01644. eCollection 2019.

The pathogenicity of the human foodborne pathogen

Cite
Harter E, Lassnig C, Wagner EM, et al. The Novel Internalins InlP1 and InlP4 and the Internalin-Like Protein InlP3 Enhance the Pathogenicity of . Front Microbiol. 2019;10:1644doi: 10.3389/fmicb.2019.01644.
Harter, E., Lassnig, C., Wagner, E. M., Zaiser, A., Wagner, M., & Rychli, K. (2019). The Novel Internalins InlP1 and InlP4 and the Internalin-Like Protein InlP3 Enhance the Pathogenicity of . Frontiers in microbiology, 101644. https://doi.org/10.3389/fmicb.2019.01644
Harter, Eva, et al. "The Novel Internalins InlP1 and InlP4 and the Internalin-Like Protein InlP3 Enhance the Pathogenicity of ." Frontiers in microbiology vol. 10 (2019): 1644. doi: https://doi.org/10.3389/fmicb.2019.01644
Harter E, Lassnig C, Wagner EM, Zaiser A, Wagner M, Rychli K. The Novel Internalins InlP1 and InlP4 and the Internalin-Like Protein InlP3 Enhance the Pathogenicity of . Front Microbiol. 2019 Jul 23;10:1644. doi: 10.3389/fmicb.2019.01644. eCollection 2019. PMID: 31396177; PMCID: PMC6664051.
Copy Download .nbib Format: NLM
Charcot and Pasteur: intersecting orbits in fin de siècle French medicine.

Journal of the history of the neurosciences

Goetz CG, Harter DH.
PMID: 20183219
J Hist Neurosci. 2009 Oct;18(4):378-86. doi: 10.1080/09647040802536967.

Charcot and Pasteur were scientific contemporaries, but their relationship has not been extensively studied. We analyzed available source documents from the Charcot Library, Bibliothèque Nationale, Institute Pasteur, and Pasteur Library. These documents demonstrate that in spite of geographical proximity,...

Cite
Goetz CG, Harter DH. Charcot and Pasteur: intersecting orbits in fin de siècle French medicine. J Hist Neurosci. 2009;18(4):378-86doi: 10.1080/09647040802536967.
Goetz, C. G., & Harter, D. H. (2009). Charcot and Pasteur: intersecting orbits in fin de siècle French medicine. Journal of the history of the neurosciences, 18(4), 378-86. https://doi.org/10.1080/09647040802536967
Goetz, Christopher G, and Harter, Donald H. "Charcot and Pasteur: intersecting orbits in fin de siècle French medicine." Journal of the history of the neurosciences vol. 18,4 (2009): 378-86. doi: https://doi.org/10.1080/09647040802536967
Goetz CG, Harter DH. Charcot and Pasteur: intersecting orbits in fin de siècle French medicine. J Hist Neurosci. 2009 Oct;18(4):378-86. doi: 10.1080/09647040802536967. PMID: 20183219.
Copy Download .nbib Format: NLM
RanBPM expression regulates transcriptional pathways involved in development and tumorigenesis.

American journal of cancer research

Atabakhsh E, Wang JH, Wang X, Carter DE, Schild-Poulter C.
PMID: 22957307
Am J Cancer Res. 2012;2(5):549-65. Epub 2012 Aug 20.

RanBPM is a ubiquitous protein that has been reported to regulate several cellular processes through interactions with various proteins. However, it is not known whether RanBPM may regulate gene expression patterns. As it has been shown that RanBPM interacts...

Cite
Atabakhsh E, Wang JH, Wang X, et al. RanBPM expression regulates transcriptional pathways involved in development and tumorigenesis. Am J Cancer Res. 2012;2(5):549-65
Atabakhsh, E., Wang, J. H., Wang, X., Carter, D. E., & Schild-Poulter, C. (2012). RanBPM expression regulates transcriptional pathways involved in development and tumorigenesis. American journal of cancer research, 2(5), 549-65.
Atabakhsh, Elnaz, et al. "RanBPM expression regulates transcriptional pathways involved in development and tumorigenesis." American journal of cancer research vol. 2,5 (2012): 549-65.
Atabakhsh E, Wang JH, Wang X, Carter DE, Schild-Poulter C. RanBPM expression regulates transcriptional pathways involved in development and tumorigenesis. Am J Cancer Res. 2012;2(5):549-65. Epub 2012 Aug 20. PMID: 22957307; PMCID: PMC3433104.
Copy Download .nbib Format: NLM
Pramipexole extended release: a novel treatment option in Parkinson's disease.

Parkinson's disease

Eisenreich W, Sommer B, Hartter S, Jost WH.
PMID: 21209705
Parkinsons Dis. 2010 Dec 19;2010:612619. doi: 10.4061/2010/612619.

Pramipexole, the most commonly prescribed dopamine agonist worldwide, meanwhile serves as a reference substance for evaluation of new drugs. Based on numerous clinical data and vast experiences, efficacy and safety profiles of this non-ergoline dopamine agonist are well characterized....

Cite
Eisenreich W, Sommer B, Hartter S, et al. Pramipexole extended release: a novel treatment option in Parkinson's disease. Parkinsons Dis. 2010;2010:612619doi: 10.4061/2010/612619.
Eisenreich, W., Sommer, B., Hartter, S., & Jost, W. H. (2010). Pramipexole extended release: a novel treatment option in Parkinson's disease. Parkinson's disease, 2010612619. https://doi.org/10.4061/2010/612619
Eisenreich, Wolfram, et al. "Pramipexole extended release: a novel treatment option in Parkinson's disease." Parkinson's disease vol. 2010 (2010): 612619. doi: https://doi.org/10.4061/2010/612619
Eisenreich W, Sommer B, Hartter S, Jost WH. Pramipexole extended release: a novel treatment option in Parkinson's disease. Parkinsons Dis. 2010 Dec 19;2010:612619. doi: 10.4061/2010/612619. PMID: 21209705; PMCID: PMC3010659.
Copy Download .nbib Format: NLM
The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts.

Journal of cell communication and signaling

Chen S, McLean S, Carter DE, Leask A.
PMID: 18600477
J Cell Commun Signal. 2007 Dec;1(3):175-83. doi: 10.1007/s12079-007-0015-x. Epub 2008 Jan 20.

Wnt proteins play important roles in regulating cell differentiation, proliferation and polarity. Wnts have been proposed to play roles in tissue repair and fibrosis, yet the gene expression profile of fibroblasts exposed to Wnts has not been examined. We...

Cite
Chen S, McLean S, Carter DE, et al. The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts. J Cell Commun Signal. 2008;1(3):175-83doi: 10.1007/s12079-007-0015-x.
Chen, S., McLean, S., Carter, D. E., & Leask, A. (2007). The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts. Journal of cell communication and signaling, 1(3), 175-83. https://doi.org/10.1007/s12079-007-0015-x
Chen, Shaoqiong, et al. "The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts." Journal of cell communication and signaling vol. 1,3 (2007): 175-83. doi: https://doi.org/10.1007/s12079-007-0015-x
Chen S, McLean S, Carter DE, Leask A. The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts. J Cell Commun Signal. 2007 Dec;1(3):175-83. doi: 10.1007/s12079-007-0015-x. Epub 2008 Jan 20. PMID: 18600477; PMCID: PMC2443233.
Copy Download .nbib Format: NLM
Current concepts of apoptosis.

Neurosurgical focus

Harter DH, Doherty PF, Chin LS.
PMID: 15104418
Neurosurg Focus. 1997 Sep 15;3(3):e6. doi: 10.3171/foc.1997.3.3.9.

Apoptosis is a carefully regulated process involved in developmental and immunological events. The alteration of apoptotic pathways is important in the establishment and progression of neoplasia. Apoptosis allows for the orderly removal of excess cells but, in contrast to...

Cite
Harter DH, Doherty PF, Chin LS. Current concepts of apoptosis. Neurosurg Focus. 1997;3(3):e6doi: 10.3171/foc.1997.3.3.9.
Harter, D. H., Doherty, P. F., & Chin, L. S. (1997). Current concepts of apoptosis. Neurosurgical focus, 3(3), e6. https://doi.org/10.3171/foc.1997.3.3.9
Harter, D H, et al. "Current concepts of apoptosis." Neurosurgical focus vol. 3,3 (1997): e6. doi: https://doi.org/10.3171/foc.1997.3.3.9
Harter DH, Doherty PF, Chin LS. Current concepts of apoptosis. Neurosurg Focus. 1997 Sep 15;3(3):e6. doi: 10.3171/foc.1997.3.3.9. PMID: 15104418.
Copy Download .nbib Format: NLM
Lithium heat-pipe arc lamp.

Applied optics

Boyd RW, Harter DJ.
PMID: 20234485
Appl Opt. 1980 Aug 15;19(16):2660-1. doi: 10.1364/AO.19.002660.

No abstract available.

Cite
Boyd RW, Harter DJ. Lithium heat-pipe arc lamp. Appl Opt. 1980;19(16):2660-1doi: 10.1364/AO.19.002660.
Boyd, R. W., & Harter, D. J. (1980). Lithium heat-pipe arc lamp. Applied optics, 19(16), 2660-1. https://doi.org/10.1364/AO.19.002660
Boyd, R W, and Harter, D J. "Lithium heat-pipe arc lamp." Applied optics vol. 19,16 (1980): 2660-1. doi: https://doi.org/10.1364/AO.19.002660
Boyd RW, Harter DJ. Lithium heat-pipe arc lamp. Appl Opt. 1980 Aug 15;19(16):2660-1. doi: 10.1364/AO.19.002660. PMID: 20234485.
Copy Download .nbib Format: NLM
Fiber-laser-based femtosecond parametric generator in bulk periodically poled LiNbO(3).

Optics letters

Galvanauskas A, Arbore MA, Fejer MM, Fermann ME, Harter D.
PMID: 18183117
Opt Lett. 1997 Jan 15;22(2):105-7. doi: 10.1364/ol.22.000105.

A diode-pumped system for optical parametric generation of wavelength-tunable femtosecond pulses is demonstrated. It comprises an Er-doped fiber mode-locked laser, a fiber chirped-pulse amplifier, and a bulk periodically poled LiNbO(3) (PPLN) optical parametric generator. The parametric generator is pumped...

Cite
Galvanauskas A, Arbore MA, Fejer MM, et al. Fiber-laser-based femtosecond parametric generator in bulk periodically poled LiNbO(3). Opt Lett. 1997;22(2):105-7doi: 10.1364/ol.22.000105.
Galvanauskas, A., Arbore, M. A., Fejer, M. M., Fermann, M. E., & Harter, D. (1997). Fiber-laser-based femtosecond parametric generator in bulk periodically poled LiNbO(3). Optics letters, 22(2), 105-7. https://doi.org/10.1364/ol.22.000105
Galvanauskas, A, et al. "Fiber-laser-based femtosecond parametric generator in bulk periodically poled LiNbO(3)." Optics letters vol. 22,2 (1997): 105-7. doi: https://doi.org/10.1364/ol.22.000105
Galvanauskas A, Arbore MA, Fejer MM, Fermann ME, Harter D. Fiber-laser-based femtosecond parametric generator in bulk periodically poled LiNbO(3). Opt Lett. 1997 Jan 15;22(2):105-7. doi: 10.1364/ol.22.000105. PMID: 18183117.
Copy Download .nbib Format: NLM
Low-magnification unstable resonators used with ruby and alexandrite lasers.

Optics letters

Harter DJ, Walling JC.
PMID: 19738734
Opt Lett. 1986 Nov 01;11(11):706-8. doi: 10.1364/ol.11.000706.

Low-magnification unstable resonators that utilize radially birefringent elements and that have been shown to be suitable for use with ruby and alexandrite lasers are described. From these resonators, 400 mJ of energy in a Q-switched pulse with ~2.5x diffraction-limited...

Cite
Harter DJ, Walling JC. Low-magnification unstable resonators used with ruby and alexandrite lasers. Opt Lett. 1986;11(11):706-8doi: 10.1364/ol.11.000706.
Harter, D. J., & Walling, J. C. (1986). Low-magnification unstable resonators used with ruby and alexandrite lasers. Optics letters, 11(11), 706-8. https://doi.org/10.1364/ol.11.000706
Harter, D J, and Walling, J C. "Low-magnification unstable resonators used with ruby and alexandrite lasers." Optics letters vol. 11,11 (1986): 706-8. doi: https://doi.org/10.1364/ol.11.000706
Harter DJ, Walling JC. Low-magnification unstable resonators used with ruby and alexandrite lasers. Opt Lett. 1986 Nov 01;11(11):706-8. doi: 10.1364/ol.11.000706. PMID: 19738734.
Copy Download .nbib Format: NLM
Glioblastoma multiforme: State of the art and future therapeutics.

Surgical neurology international

Wilson TA, Karajannis MA, Harter DH.
PMID: 24991467
Surg Neurol Int. 2014 May 08;5:64. doi: 10.4103/2152-7806.132138. eCollection 2014.

BACKGROUND: Glioblastoma multiforme (GBM) is the most common and lethal primary malignancy of the central nervous system (CNS). Despite the proven benefit of surgical resection and aggressive treatment with chemo- and radiotherapy, the prognosis remains very poor. Recent advances...

Cite
Wilson TA, Karajannis MA, Harter DH. Glioblastoma multiforme: State of the art and future therapeutics. Surg Neurol Int. 2014;5:64doi: 10.4103/2152-7806.132138.
Wilson, T. A., Karajannis, M. A., & Harter, D. H. (2014). Glioblastoma multiforme: State of the art and future therapeutics. Surgical neurology international, 564. https://doi.org/10.4103/2152-7806.132138
Wilson, Taylor A, et al. "Glioblastoma multiforme: State of the art and future therapeutics." Surgical neurology international vol. 5 (2014): 64. doi: https://doi.org/10.4103/2152-7806.132138
Wilson TA, Karajannis MA, Harter DH. Glioblastoma multiforme: State of the art and future therapeutics. Surg Neurol Int. 2014 May 08;5:64. doi: 10.4103/2152-7806.132138. eCollection 2014. PMID: 24991467; PMCID: PMC4078454.
Copy Download .nbib Format: NLM
Can training extend current guidelines for cochlear implant candidacy?.

Neural regeneration research

Isaiah A, Hartley DE.
PMID: 26109944
Neural Regen Res. 2015 May;10(5):718-20. doi: 10.4103/1673-5374.156964.

No abstract available.

Cite
Isaiah A, Hartley DE. Can training extend current guidelines for cochlear implant candidacy?. Neural Regen Res. 2015;10(5):718-20doi: 10.4103/1673-5374.156964.
Isaiah, A., & Hartley, D. E. (2015). Can training extend current guidelines for cochlear implant candidacy?. Neural regeneration research, 10(5), 718-20. https://doi.org/10.4103/1673-5374.156964
Isaiah, Amal, and Hartley, Douglas E H. "Can training extend current guidelines for cochlear implant candidacy?." Neural regeneration research vol. 10,5 (2015): 718-20. doi: https://doi.org/10.4103/1673-5374.156964
Isaiah A, Hartley DE. Can training extend current guidelines for cochlear implant candidacy?. Neural Regen Res. 2015 May;10(5):718-20. doi: 10.4103/1673-5374.156964. PMID: 26109944; PMCID: PMC4468761.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 72 entries